

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 5.83081076 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.56167200 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.56167200 |
| 4 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.87893950 |
| 5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.82650828 |
| 6 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.66860225 |
| 7 | positive regulation of vasculogenesis (GO:2001214) | 4.48774633 |
| 8 | morphogenesis of an endothelium (GO:0003159) | 4.44369341 |
| 9 | endothelial tube morphogenesis (GO:0061154) | 4.44369341 |
| 10 | neutrophil activation involved in immune response (GO:0002283) | 4.38305283 |
| 11 | definitive hemopoiesis (GO:0060216) | 4.38082320 |
| 12 | negative regulation of cell killing (GO:0031342) | 4.30782493 |
| 13 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.30782493 |
| 14 | blood vessel maturation (GO:0001955) | 4.27229935 |
| 15 | viral transcription (GO:0019083) | 4.20650491 |
| 16 | angiogenesis involved in wound healing (GO:0060055) | 4.20428079 |
| 17 | endothelium development (GO:0003158) | 4.16899891 |
| 18 | platelet dense granule organization (GO:0060155) | 4.04598115 |
| 19 | translational termination (GO:0006415) | 3.99505922 |
| 20 | DNA deamination (GO:0045006) | 3.95581268 |
| 21 | negative thymic T cell selection (GO:0045060) | 3.94314185 |
| 22 | negative T cell selection (GO:0043383) | 3.93005274 |
| 23 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.92978826 |
| 24 | lymph vessel development (GO:0001945) | 3.92447564 |
| 25 | positive regulation of B cell differentiation (GO:0045579) | 3.89743415 |
| 26 | negative regulation of phagocytosis (GO:0050765) | 3.84812130 |
| 27 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.80888705 |
| 28 | regulation of regulatory T cell differentiation (GO:0045589) | 3.71541756 |
| 29 | positive regulation of granulocyte differentiation (GO:0030854) | 3.62059688 |
| 30 | response to interferon-beta (GO:0035456) | 3.60746835 |
| 31 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.60199819 |
| 32 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.59600994 |
| 33 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.59471125 |
| 34 | megakaryocyte development (GO:0035855) | 3.56563172 |
| 35 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.55340664 |
| 36 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.54697480 |
| 37 | ribosomal small subunit biogenesis (GO:0042274) | 3.53665294 |
| 38 | cotranslational protein targeting to membrane (GO:0006613) | 3.50272935 |
| 39 | protein targeting to ER (GO:0045047) | 3.48385980 |
| 40 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.46692063 |
| 41 | regulation of vasculogenesis (GO:2001212) | 3.45688687 |
| 42 | translational elongation (GO:0006414) | 3.44752973 |
| 43 | regulation of gamma-delta T cell activation (GO:0046643) | 3.41363747 |
| 44 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.33320522 |
| 45 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.30813557 |
| 46 | protein localization to endoplasmic reticulum (GO:0070972) | 3.30094801 |
| 47 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.29707206 |
| 48 | response to interleukin-15 (GO:0070672) | 3.21075523 |
| 49 | regulation of T cell tolerance induction (GO:0002664) | 3.21009291 |
| 50 | leukocyte aggregation (GO:0070486) | 3.20544020 |
| 51 | thrombin receptor signaling pathway (GO:0070493) | 3.18107680 |
| 52 | cellular response to interleukin-15 (GO:0071350) | 3.16797744 |
| 53 | cellular response to zinc ion (GO:0071294) | 3.16654162 |
| 54 | neutrophil activation (GO:0042119) | 3.16626403 |
| 55 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.14754819 |
| 56 | tolerance induction (GO:0002507) | 3.13885288 |
| 57 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.12018571 |
| 58 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.10618524 |
| 59 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.09788136 |
| 60 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.09696904 |
| 61 | viral life cycle (GO:0019058) | 3.08351544 |
| 62 | secretory granule organization (GO:0033363) | 3.06890758 |
| 63 | maturation of SSU-rRNA (GO:0030490) | 3.06682236 |
| 64 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.06123081 |
| 65 | regulation of B cell differentiation (GO:0045577) | 3.03413679 |
| 66 | positive regulation of interleukin-8 secretion (GO:2000484) | 3.03139284 |
| 67 | mast cell activation (GO:0045576) | 3.02291071 |
| 68 | positive regulation of tolerance induction (GO:0002645) | 3.02036647 |
| 69 | thymic T cell selection (GO:0045061) | 3.01724775 |
| 70 | B cell receptor signaling pathway (GO:0050853) | 3.01464470 |
| 71 | positive regulation of lamellipodium assembly (GO:0010592) | 3.01389110 |
| 72 | detection of bacterium (GO:0016045) | 3.00438238 |
| 73 | DNA strand elongation (GO:0022616) | 2.99127361 |
| 74 | T cell homeostasis (GO:0043029) | 2.98380876 |
| 75 | regulation of antigen processing and presentation (GO:0002577) | 2.98069325 |
| 76 | detection of other organism (GO:0098543) | 2.97676055 |
| 77 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.97489575 |
| 78 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.94875252 |
| 79 | T cell selection (GO:0045058) | 2.94529215 |
| 80 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.93713970 |
| 81 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.93377534 |
| 82 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.93377534 |
| 83 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.93346389 |
| 84 | regulation of tolerance induction (GO:0002643) | 2.92240840 |
| 85 | autophagic vacuole fusion (GO:0000046) | 2.90232308 |
| 86 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.89060648 |
| 87 | cellular protein complex disassembly (GO:0043624) | 2.88452364 |
| 88 | response to type I interferon (GO:0034340) | 2.86757122 |
| 89 | positive regulation of isotype switching (GO:0045830) | 2.86164122 |
| 90 | positive T cell selection (GO:0043368) | 2.84459905 |
| 91 | telomere maintenance via recombination (GO:0000722) | 2.84186821 |
| 92 | type I interferon signaling pathway (GO:0060337) | 2.82300976 |
| 93 | cellular response to type I interferon (GO:0071357) | 2.82300976 |
| 94 | cellular extravasation (GO:0045123) | 2.81436403 |
| 95 | regulation of mast cell degranulation (GO:0043304) | 2.80920076 |
| 96 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.80753543 |
| 97 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.80563138 |
| 98 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.80563138 |
| 99 | lymph node development (GO:0048535) | 2.80181067 |
| 100 | translational initiation (GO:0006413) | 2.78770992 |
| 101 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.78471741 |
| 102 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.77876733 |
| 103 | response to protozoan (GO:0001562) | 2.76166698 |
| 104 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.75803799 |
| 105 | regulation of mast cell activation (GO:0033003) | 2.75104554 |
| 106 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.74676845 |
| 107 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.74676845 |
| 108 | modulation by symbiont of host immune response (GO:0052553) | 2.74676845 |
| 109 | positive regulation by symbiont of host defense response (GO:0052509) | 2.74676845 |
| 110 | modulation by symbiont of host defense response (GO:0052031) | 2.74676845 |
| 111 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.74676845 |
| 112 | positive regulation of antigen processing and presentation (GO:0002579) | 2.74409918 |
| 113 | positive regulation of DNA recombination (GO:0045911) | 2.73022935 |
| 114 | positive regulation of mast cell activation (GO:0033005) | 2.72971936 |
| 115 | granulocyte activation (GO:0036230) | 2.72669358 |
| 116 | regulation of endothelial cell differentiation (GO:0045601) | 2.72132792 |
| 117 | response to interferon-alpha (GO:0035455) | 2.71984105 |
| 118 | leukocyte degranulation (GO:0043299) | 2.71534174 |
| 119 | positive regulation of T cell mediated immunity (GO:0002711) | 2.70544483 |
| 120 | positive regulation of cell killing (GO:0031343) | 2.69865958 |
| 121 | cellular response to interferon-beta (GO:0035458) | 2.68965885 |
| 122 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.68633531 |
| 123 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 2.67708207 |
| 124 | Peyers patch development (GO:0048541) | 2.67113689 |
| 125 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.67113689 |
| 126 | myeloid dendritic cell activation (GO:0001773) | 2.66725662 |
| 127 | positive regulation of B cell mediated immunity (GO:0002714) | 2.65826233 |
| 128 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.65826233 |
| 129 | negative regulation of interleukin-12 production (GO:0032695) | 2.65757034 |
| 130 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.65619250 |
| 131 | immunoglobulin mediated immune response (GO:0016064) | 2.65568295 |
| 132 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.65135723 |
| 133 | negative regulation of T cell apoptotic process (GO:0070233) | 2.64894627 |
| 134 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.64642039 |
| 135 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.64457950 |
| 136 | defense response to protozoan (GO:0042832) | 2.63100089 |
| 137 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.61864063 |
| 138 | interferon-gamma production (GO:0032609) | 2.61404882 |
| 139 | germinal center formation (GO:0002467) | 2.60825935 |
| 140 | positive regulation of lamellipodium organization (GO:1902745) | 2.60420566 |
| 141 | regulation of erythrocyte differentiation (GO:0045646) | 2.58282284 |
| 142 | embryonic hemopoiesis (GO:0035162) | 2.57844439 |
| 143 | regulation of necroptotic process (GO:0060544) | 2.56242422 |
| 144 | protein complex disassembly (GO:0043241) | 2.51980876 |
| 145 | mitotic recombination (GO:0006312) | 2.51649353 |
| 146 | positive regulation of DNA biosynthetic process (GO:2000573) | 2.50272939 |
| 147 | positive thymic T cell selection (GO:0045059) | 2.50250647 |
| 148 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.48462998 |
| 149 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.47334621 |
| 150 | necroptotic process (GO:0070266) | 2.46959547 |
| 151 | mast cell degranulation (GO:0043303) | 2.46843012 |
| 152 | mast cell activation involved in immune response (GO:0002279) | 2.46843012 |
| 153 | surfactant homeostasis (GO:0043129) | 2.45822629 |
| 154 | sprouting angiogenesis (GO:0002040) | 2.45264813 |
| 155 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.42993462 |
| 156 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.42692525 |
| 157 | B cell mediated immunity (GO:0019724) | 2.41930449 |
| 158 | lymphocyte homeostasis (GO:0002260) | 2.41424786 |
| 159 | actin nucleation (GO:0045010) | 2.38407858 |
| 160 | regulation of apoptotic cell clearance (GO:2000425) | 2.37963601 |
| 161 | mRNA catabolic process (GO:0006402) | 2.36325049 |
| 162 | telomere maintenance via telomere lengthening (GO:0010833) | 2.35812569 |
| 163 | T cell migration (GO:0072678) | 2.34222091 |
| 164 | negative regulation of stress fiber assembly (GO:0051497) | 2.34103607 |
| 165 | DNA replication initiation (GO:0006270) | 2.32592438 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.41821478 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.55124145 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.47835399 |
| 4 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.41954680 |
| 5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.21988654 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.12566554 |
| 7 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.99221173 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.98836024 |
| 9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.92588027 |
| 10 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.84274474 |
| 11 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.70594240 |
| 12 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.63439322 |
| 13 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.56520033 |
| 14 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.46058108 |
| 15 | * MYC_22102868_ChIP-Seq_BL_Human | 2.43223010 |
| 16 | GATA1_22025678_ChIP-Seq_K562_Human | 2.42690508 |
| 17 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.40908957 |
| 18 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.40122389 |
| 19 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.39387926 |
| 20 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.37858934 |
| 21 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.19725695 |
| 22 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.17577025 |
| 23 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.16516478 |
| 24 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.08453590 |
| 25 | MAF_26560356_Chip-Seq_TH1_Human | 2.05716455 |
| 26 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.03145058 |
| 27 | MYB_26560356_Chip-Seq_TH2_Human | 2.00758621 |
| 28 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.94107336 |
| 29 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.89547905 |
| 30 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.88459744 |
| 31 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.84511947 |
| 32 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.83400705 |
| 33 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.82063152 |
| 34 | MYB_26560356_Chip-Seq_TH1_Human | 1.81026520 |
| 35 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.80315807 |
| 36 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.80152151 |
| 37 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.79729536 |
| 38 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.78834875 |
| 39 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.78080875 |
| 40 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.77744999 |
| 41 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.77008416 |
| 42 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.75147162 |
| 43 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.74324752 |
| 44 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.74035784 |
| 45 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.72011625 |
| 46 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.71400265 |
| 47 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.70587730 |
| 48 | GATA3_26560356_Chip-Seq_TH2_Human | 1.68528954 |
| 49 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.65780269 |
| 50 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 1.65057576 |
| 51 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.64597712 |
| 52 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.62094745 |
| 53 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.61885738 |
| 54 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.60693298 |
| 55 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.57786789 |
| 56 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.57615466 |
| 57 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.56830410 |
| 58 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.55122970 |
| 59 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.54856728 |
| 60 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.54304318 |
| 61 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.53381314 |
| 62 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.51185511 |
| 63 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.51057280 |
| 64 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.50944686 |
| 65 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.47939343 |
| 66 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.47221359 |
| 67 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.46009073 |
| 68 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.43322854 |
| 69 | SPI1_23127762_ChIP-Seq_K562_Human | 1.41514019 |
| 70 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.39460849 |
| 71 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.38041871 |
| 72 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.35704247 |
| 73 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.33958419 |
| 74 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.32750785 |
| 75 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.32419596 |
| 76 | MAF_26560356_Chip-Seq_TH2_Human | 1.31305417 |
| 77 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.29049429 |
| 78 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.28050209 |
| 79 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.27487683 |
| 80 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.26868933 |
| 81 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.24452070 |
| 82 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.24096545 |
| 83 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.23151278 |
| 84 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.22475009 |
| 85 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.20998360 |
| 86 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.20875710 |
| 87 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.20025499 |
| 88 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.19778065 |
| 89 | P300_27268052_Chip-Seq_Bcells_Human | 1.15934991 |
| 90 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.15489478 |
| 91 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.14052690 |
| 92 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.13956132 |
| 93 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.13255892 |
| 94 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.12441687 |
| 95 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.12396151 |
| 96 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.11714861 |
| 97 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.09470456 |
| 98 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.09149485 |
| 99 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.08707758 |
| 100 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.08103014 |
| 101 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07343748 |
| 102 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.07104398 |
| 103 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.06072153 |
| 104 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.05042153 |
| 105 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04628096 |
| 106 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.04609464 |
| 107 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.04194168 |
| 108 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01811181 |
| 109 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01734651 |
| 110 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01325150 |
| 111 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.00907202 |
| 112 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.00761583 |
| 113 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.00175724 |
| 114 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.99210251 |
| 115 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.98478564 |
| 116 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.97620918 |
| 117 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.97358161 |
| 118 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.96718594 |
| 119 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.94873897 |
| 120 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.94183616 |
| 121 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.93975292 |
| 122 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.93433691 |
| 123 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92686490 |
| 124 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91427127 |
| 125 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91170272 |
| 126 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.90771641 |
| 127 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.90485830 |
| 128 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.90433455 |
| 129 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90383668 |
| 130 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.89752172 |
| 131 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89746362 |
| 132 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89007666 |
| 133 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.88678012 |
| 134 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.85627071 |
| 135 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.80887890 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010368_abnormal_lymphatic_system | 3.87969425 |
| 2 | MP0003724_increased_susceptibility_to | 3.86234291 |
| 3 | MP0001879_abnormal_lymphatic_vessel | 3.64719887 |
| 4 | MP0002396_abnormal_hematopoietic_system | 3.19342929 |
| 5 | MP0001835_abnormal_antigen_presentation | 2.86480130 |
| 6 | MP0006054_spinal_hemorrhage | 2.77997547 |
| 7 | MP0005671_abnormal_response_to | 2.54978280 |
| 8 | MP0009785_altered_susceptibility_to | 2.52816104 |
| 9 | MP0003763_abnormal_thymus_physiology | 2.50860736 |
| 10 | MP0000465_gastrointestinal_hemorrhage | 2.43604335 |
| 11 | MP0005167_abnormal_blood-brain_barrier | 2.41419776 |
| 12 | MP0000685_abnormal_immune_system | 2.38187931 |
| 13 | MP0002166_altered_tumor_susceptibility | 2.31058435 |
| 14 | MP0004808_abnormal_hematopoietic_stem | 2.24320826 |
| 15 | MP0001800_abnormal_humoral_immune | 2.16778469 |
| 16 | MP0001545_abnormal_hematopoietic_system | 2.15441981 |
| 17 | MP0005397_hematopoietic_system_phenotyp | 2.15441981 |
| 18 | MP0005025_abnormal_response_to | 2.12492552 |
| 19 | MP0005464_abnormal_platelet_physiology | 2.07168375 |
| 20 | * MP0002420_abnormal_adaptive_immunity | 2.03471149 |
| 21 | * MP0002398_abnormal_bone_marrow | 2.01955529 |
| 22 | MP0009333_abnormal_splenocyte_physiolog | 2.01716840 |
| 23 | * MP0001819_abnormal_immune_cell | 1.99650678 |
| 24 | MP0002452_abnormal_antigen_presenting | 1.98448883 |
| 25 | MP0005387_immune_system_phenotype | 1.98223283 |
| 26 | MP0001790_abnormal_immune_system | 1.98223283 |
| 27 | MP0003828_pulmonary_edema | 1.93926745 |
| 28 | MP0005000_abnormal_immune_tolerance | 1.93720077 |
| 29 | MP0002723_abnormal_immune_serum | 1.89372444 |
| 30 | MP0006082_CNS_inflammation | 1.87475641 |
| 31 | MP0002419_abnormal_innate_immunity | 1.86807008 |
| 32 | MP0003436_decreased_susceptibility_to | 1.84175433 |
| 33 | MP0002148_abnormal_hypersensitivity_rea | 1.83536525 |
| 34 | MP0000716_abnormal_immune_system | 1.77803795 |
| 35 | MP0001853_heart_inflammation | 1.76279606 |
| 36 | MP0004147_increased_porphyrin_level | 1.75250203 |
| 37 | MP0000689_abnormal_spleen_morphology | 1.73774876 |
| 38 | MP0003191_abnormal_cellular_cholesterol | 1.69846564 |
| 39 | MP0002722_abnormal_immune_system | 1.68671820 |
| 40 | MP0010155_abnormal_intestine_physiology | 1.67444552 |
| 41 | MP0002429_abnormal_blood_cell | 1.67008314 |
| 42 | MP0002405_respiratory_system_inflammati | 1.64520929 |
| 43 | MP0001873_stomach_inflammation | 1.60409147 |
| 44 | MP0005084_abnormal_gallbladder_morpholo | 1.56669785 |
| 45 | MP0009379_abnormal_foot_pigmentation | 1.54413795 |
| 46 | MP0002006_tumorigenesis | 1.53525324 |
| 47 | MP0003303_peritoneal_inflammation | 1.49514176 |
| 48 | MP0002138_abnormal_hepatobiliary_system | 1.44952825 |
| 49 | MP0000343_altered_response_to | 1.43572027 |
| 50 | MP0000490_abnormal_crypts_of | 1.43528538 |
| 51 | MP0002132_abnormal_respiratory_system | 1.42459567 |
| 52 | MP0005174_abnormal_tail_pigmentation | 1.40881485 |
| 53 | MP0009278_abnormal_bone_marrow | 1.40084738 |
| 54 | MP0000249_abnormal_blood_vessel | 1.37407996 |
| 55 | MP0000703_abnormal_thymus_morphology | 1.36962527 |
| 56 | MP0000767_abnormal_smooth_muscle | 1.36071508 |
| 57 | MP0003693_abnormal_embryo_hatching | 1.32811105 |
| 58 | MP0001845_abnormal_inflammatory_respons | 1.27035242 |
| 59 | MP0005075_abnormal_melanosome_morpholog | 1.20442696 |
| 60 | MP0008004_abnormal_stomach_pH | 1.20143656 |
| 61 | MP0001533_abnormal_skeleton_physiology | 1.19102959 |
| 62 | MP0003866_abnormal_defecation | 1.14694938 |
| 63 | MP0003806_abnormal_nucleotide_metabolis | 1.12701247 |
| 64 | MP0003943_abnormal_hepatobiliary_system | 1.11362386 |
| 65 | MP0004782_abnormal_surfactant_physiolog | 1.10145478 |
| 66 | MP0003077_abnormal_cell_cycle | 1.08032126 |
| 67 | MP0004272_abnormal_basement_membrane | 1.07903533 |
| 68 | MP0010094_abnormal_chromosome_stability | 1.06288265 |
| 69 | MP0008007_abnormal_cellular_replicative | 1.06155567 |
| 70 | MP0008469_abnormal_protein_level | 1.05485643 |
| 71 | MP0003279_aneurysm | 1.05238450 |
| 72 | MP0005409_darkened_coat_color | 1.03452110 |
| 73 | MP0003300_gastrointestinal_ulcer | 1.00606580 |
| 74 | MP0002019_abnormal_tumor_incidence | 0.99819602 |
| 75 | MP0005310_abnormal_salivary_gland | 0.99249785 |
| 76 | MP0004947_skin_inflammation | 0.98800852 |
| 77 | MP0004084_abnormal_cardiac_muscle | 0.97874403 |
| 78 | MP0002095_abnormal_skin_pigmentation | 0.95395684 |
| 79 | MP0008057_abnormal_DNA_replication | 0.94168402 |
| 80 | MP0001851_eye_inflammation | 0.93692154 |
| 81 | MP0003567_abnormal_fetal_cardiomyocyte | 0.91263433 |
| 82 | MP0001915_intracranial_hemorrhage | 0.89866658 |
| 83 | MP0000858_altered_metastatic_potential | 0.88741223 |
| 84 | MP0005165_increased_susceptibility_to | 0.88615490 |
| 85 | MP0005166_decreased_susceptibility_to | 0.87853145 |
| 86 | MP0009697_abnormal_copulation | 0.86219850 |
| 87 | MP0000015_abnormal_ear_pigmentation | 0.85992487 |
| 88 | MP0002933_joint_inflammation | 0.83794515 |
| 89 | MP0003638_abnormal_response/metabolism_ | 0.81611392 |
| 90 | MP0004484_altered_response_of | 0.80061437 |
| 91 | MP0002128_abnormal_blood_circulation | 0.79418346 |
| 92 | MP0005023_abnormal_wound_healing | 0.78947124 |
| 93 | MP0003045_fibrosis | 0.78664750 |
| 94 | MP0004957_abnormal_blastocyst_morpholog | 0.77740522 |
| 95 | MP0003111_abnormal_nucleus_morphology | 0.76719342 |
| 96 | MP0003566_abnormal_cell_adhesion | 0.75262466 |
| 97 | MP0005058_abnormal_lysosome_morphology | 0.74703021 |
| 98 | MP0009764_decreased_sensitivity_to | 0.74582668 |
| 99 | MP0004510_myositis | 0.73881292 |
| 100 | MP0006036_abnormal_mitochondrial_physio | 0.73237647 |
| 101 | MP0003448_altered_tumor_morphology | 0.72333059 |
| 102 | MP0003075_altered_response_to | 0.72321963 |
| 103 | MP0004883_abnormal_blood_vessel | 0.72154348 |
| 104 | MP0009765_abnormal_xenobiotic_induced | 0.72042871 |
| 105 | MP0005385_cardiovascular_system_phenoty | 0.71847600 |
| 106 | MP0001544_abnormal_cardiovascular_syste | 0.71847600 |
| 107 | MP0001614_abnormal_blood_vessel | 0.71584644 |
| 108 | MP0002332_abnormal_exercise_endurance | 0.70501998 |
| 109 | MP0000230_abnormal_systemic_arterial | 0.69471081 |
| 110 | MP0001663_abnormal_digestive_system | 0.68549820 |
| 111 | MP0003186_abnormal_redox_activity | 0.68114833 |
| 112 | MP0005410_abnormal_fertilization | 0.67870936 |
| 113 | MP0005164_abnormal_response_to | 0.67862387 |
| 114 | MP0002998_abnormal_bone_remodeling | 0.67759254 |
| 115 | MP0009763_increased_sensitivity_to | 0.66972940 |
| 116 | MP0006138_congestive_heart_failure | 0.66086315 |
| 117 | MP0005390_skeleton_phenotype | 0.64904125 |
| 118 | MP0002925_abnormal_cardiovascular_devel | 0.64645538 |
| 119 | MP0008872_abnormal_physiological_respon | 0.62056270 |
| 120 | MP0002127_abnormal_cardiovascular_syste | 0.61967451 |
| 121 | MP0005595_abnormal_vascular_smooth | 0.58378406 |
| 122 | MP0008874_decreased_physiological_sensi | 0.56996513 |
| 123 | MP0008775_abnormal_heart_ventricle | 0.56808857 |
| 124 | MP0005535_abnormal_body_temperature | 0.56279585 |
| 125 | MP0005381_digestive/alimentary_phenotyp | 0.56047480 |
| 126 | MP0002277_abnormal_respiratory_mucosa | 0.55241581 |
| 127 | MP0005645_abnormal_hypothalamus_physiol | 0.53032660 |
| 128 | MP0002693_abnormal_pancreas_physiology | 0.52626423 |
| 129 | MP0008873_increased_physiological_sensi | 0.51935251 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Spontaneous hematomas (HP:0007420) | 5.14661802 |
| 2 | Abnormality of the nasal mucosa (HP:0000433) | 5.04023397 |
| 3 | Stomatitis (HP:0010280) | 4.53604675 |
| 4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.53559878 |
| 5 | Thrombocytosis (HP:0001894) | 4.37810386 |
| 6 | IgM deficiency (HP:0002850) | 4.13594527 |
| 7 | Chronic otitis media (HP:0000389) | 3.89565931 |
| 8 | Prolonged bleeding time (HP:0003010) | 3.89106289 |
| 9 | Abnormal number of erythroid precursors (HP:0012131) | 3.87694933 |
| 10 | Petechiae (HP:0000967) | 3.86136023 |
| 11 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.81573605 |
| 12 | Reticulocytopenia (HP:0001896) | 3.75598705 |
| 13 | Recurrent bronchitis (HP:0002837) | 3.66001683 |
| 14 | Hematochezia (HP:0002573) | 3.65999873 |
| 15 | Menorrhagia (HP:0000132) | 3.62668124 |
| 16 | Polycythemia (HP:0001901) | 3.56732575 |
| 17 | Increased IgM level (HP:0003496) | 3.54472551 |
| 18 | Autoimmune hemolytic anemia (HP:0001890) | 3.49140424 |
| 19 | Recurrent abscess formation (HP:0002722) | 3.48688345 |
| 20 | Myositis (HP:0100614) | 3.43528390 |
| 21 | Aplastic anemia (HP:0001915) | 3.40082695 |
| 22 | Retrobulbar optic neuritis (HP:0100654) | 3.33185428 |
| 23 | Optic neuritis (HP:0100653) | 3.33185428 |
| 24 | Encephalitis (HP:0002383) | 3.29488348 |
| 25 | Nasal polyposis (HP:0100582) | 3.27350452 |
| 26 | Epistaxis (HP:0000421) | 3.27196064 |
| 27 | Recurrent viral infections (HP:0004429) | 3.15321295 |
| 28 | Microcytic anemia (HP:0001935) | 3.14778403 |
| 29 | Eczematoid dermatitis (HP:0000976) | 3.12608045 |
| 30 | Reduced antithrombin III activity (HP:0001976) | 3.05022471 |
| 31 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.03822066 |
| 32 | Recurrent fungal infections (HP:0002841) | 2.92878011 |
| 33 | Abnormality of T cell physiology (HP:0011840) | 2.91961011 |
| 34 | Cellulitis (HP:0100658) | 2.91740168 |
| 35 | Nonimmune hydrops fetalis (HP:0001790) | 2.89000023 |
| 36 | Panhypogammaglobulinemia (HP:0003139) | 2.86735915 |
| 37 | Gingival bleeding (HP:0000225) | 2.86362017 |
| 38 | Abnormality of T cells (HP:0002843) | 2.86282705 |
| 39 | Agammaglobulinemia (HP:0004432) | 2.85713307 |
| 40 | Increased mean platelet volume (HP:0011877) | 2.80873100 |
| 41 | Gastrointestinal inflammation (HP:0004386) | 2.75089414 |
| 42 | Meningitis (HP:0001287) | 2.70898999 |
| 43 | Inflammation of the large intestine (HP:0002037) | 2.69902008 |
| 44 | IgG deficiency (HP:0004315) | 2.67702818 |
| 45 | Recurrent bacterial skin infections (HP:0005406) | 2.66522607 |
| 46 | Abnormal platelet function (HP:0011869) | 2.63488890 |
| 47 | Impaired platelet aggregation (HP:0003540) | 2.63488890 |
| 48 | T lymphocytopenia (HP:0005403) | 2.61843092 |
| 49 | Abnormality of T cell number (HP:0011839) | 2.61124637 |
| 50 | Interstitial pulmonary disease (HP:0006530) | 2.60730384 |
| 51 | Pustule (HP:0200039) | 2.59901411 |
| 52 | Hypertensive crisis (HP:0100735) | 2.55768391 |
| 53 | Colitis (HP:0002583) | 2.51705123 |
| 54 | B lymphocytopenia (HP:0010976) | 2.51682992 |
| 55 | Abnormality of B cell number (HP:0010975) | 2.51682992 |
| 56 | Type I transferrin isoform profile (HP:0003642) | 2.51519490 |
| 57 | Increased IgE level (HP:0003212) | 2.43526091 |
| 58 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.41995147 |
| 59 | Hemoptysis (HP:0002105) | 2.41485649 |
| 60 | Lymphopenia (HP:0001888) | 2.40767224 |
| 61 | 11 pairs of ribs (HP:0000878) | 2.40680237 |
| 62 | Keratoconjunctivitis (HP:0001096) | 2.40603001 |
| 63 | Hyperlipoproteinemia (HP:0010980) | 2.39429627 |
| 64 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.38354182 |
| 65 | Hypergammaglobulinemia (HP:0010702) | 2.36145546 |
| 66 | Arterial thrombosis (HP:0004420) | 2.34919053 |
| 67 | Keratoconjunctivitis sicca (HP:0001097) | 2.34815999 |
| 68 | Recurrent cutaneous fungal infections (HP:0011370) | 2.32741848 |
| 69 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.32741848 |
| 70 | Leukocytosis (HP:0001974) | 2.31867589 |
| 71 | Gastrointestinal infarctions (HP:0005244) | 2.31636099 |
| 72 | Conjunctival telangiectasia (HP:0000524) | 2.26483950 |
| 73 | Pallor (HP:0000980) | 2.26325750 |
| 74 | Recurrent skin infections (HP:0001581) | 2.26302867 |
| 75 | Cerebral hemorrhage (HP:0001342) | 2.24786986 |
| 76 | Hepatosplenomegaly (HP:0001433) | 2.23020907 |
| 77 | Episodic fever (HP:0001954) | 2.20666691 |
| 78 | Pulmonary embolism (HP:0002204) | 2.20152835 |
| 79 | Severe combined immunodeficiency (HP:0004430) | 2.20010321 |
| 80 | Abnormality of iron homeostasis (HP:0011031) | 2.19533690 |
| 81 | Joint swelling (HP:0001386) | 2.19491621 |
| 82 | Purpura (HP:0000979) | 2.19291976 |
| 83 | Urticaria (HP:0001025) | 2.18712721 |
| 84 | Thyroiditis (HP:0100646) | 2.18580509 |
| 85 | Vasculitis (HP:0002633) | 2.17771500 |
| 86 | Chest pain (HP:0100749) | 2.17639318 |
| 87 | Bronchitis (HP:0012387) | 2.17091413 |
| 88 | Systemic lupus erythematosus (HP:0002725) | 2.16385749 |
| 89 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.15413769 |
| 90 | Orchitis (HP:0100796) | 2.14585251 |
| 91 | Autoimmune thrombocytopenia (HP:0001973) | 2.14454497 |
| 92 | Gastrointestinal stroma tumor (HP:0100723) | 2.14236261 |
| 93 | Mucosal telangiectasiae (HP:0100579) | 2.13585534 |
| 94 | Granulocytopenia (HP:0001913) | 2.13466189 |
| 95 | Mediastinal lymphadenopathy (HP:0100721) | 2.13337684 |
| 96 | Vertigo (HP:0002321) | 2.13319786 |
| 97 | Abnormality of the pleura (HP:0002103) | 2.11995216 |
| 98 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.09616099 |
| 99 | Abnormality of the prostate (HP:0008775) | 2.09157279 |
| 100 | Abnormality of eosinophils (HP:0001879) | 2.09054175 |
| 101 | Anorexia (HP:0002039) | 2.08726313 |
| 102 | 3-Methylglutaconic aciduria (HP:0003535) | 2.08678421 |
| 103 | Lymphoma (HP:0002665) | 2.07590888 |
| 104 | Obstructive lung disease (HP:0006536) | 2.06424231 |
| 105 | Chronic obstructive pulmonary disease (HP:0006510) | 2.06424231 |
| 106 | Eosinophilia (HP:0001880) | 2.05384667 |
| 107 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.05030210 |
| 108 | Chronic sinusitis (HP:0011109) | 2.04785380 |
| 109 | Abnormality of macrophages (HP:0004311) | 2.03846338 |
| 110 | Skin rash (HP:0000988) | 2.02744675 |
| 111 | Increased serum ferritin (HP:0003281) | 2.01089964 |
| 112 | Abnormal protein glycosylation (HP:0012346) | 2.00535684 |
| 113 | Abnormal glycosylation (HP:0012345) | 2.00535684 |
| 114 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.00535684 |
| 115 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.00535684 |
| 116 | Abnormal platelet volume (HP:0011876) | 2.00365377 |
| 117 | Pulmonary infiltrates (HP:0002113) | 2.00022154 |
| 118 | Esophageal varix (HP:0002040) | 1.99362179 |
| 119 | Hypochromic anemia (HP:0001931) | 1.98032112 |
| 120 | Hypoplasia of the thymus (HP:0000778) | 1.97132709 |
| 121 | Verrucae (HP:0200043) | 1.92873407 |
| 122 | Papilloma (HP:0012740) | 1.92873407 |
| 123 | Combined immunodeficiency (HP:0005387) | 1.92418462 |
| 124 | Albinism (HP:0001022) | 1.92389936 |
| 125 | IgA deficiency (HP:0002720) | 1.91354287 |
| 126 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.91060510 |
| 127 | Pancytopenia (HP:0001876) | 1.90119122 |
| 128 | Papilledema (HP:0001085) | 1.87964590 |
| 129 | Thrombophlebitis (HP:0004418) | 1.87536360 |
| 130 | Fatigue (HP:0012378) | 1.87436887 |
| 131 | Macrocytic anemia (HP:0001972) | 1.86476479 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 6.25272639 |
| 2 | KDR | 4.82293854 |
| 3 | MAP4K1 | 3.82314898 |
| 4 | TGFBR2 | 3.12670734 |
| 5 | TGFBR1 | 2.92868117 |
| 6 | RIPK4 | 2.62267813 |
| 7 | TEC | 2.46214917 |
| 8 | KIT | 2.24522148 |
| 9 | BTK | 2.02571128 |
| 10 | ERN1 | 1.97900325 |
| 11 | ZAP70 | 1.94664560 |
| 12 | TXK | 1.89735956 |
| 13 | NME2 | 1.79440825 |
| 14 | MAP2K3 | 1.73913556 |
| 15 | BLK | 1.68325623 |
| 16 | VRK2 | 1.60345841 |
| 17 | TBK1 | 1.59253071 |
| 18 | JAK3 | 1.52541114 |
| 19 | TNK2 | 1.51514793 |
| 20 | PIM2 | 1.48109750 |
| 21 | IRAK4 | 1.47435748 |
| 22 | STK10 | 1.46979592 |
| 23 | IKBKE | 1.41450022 |
| 24 | TYK2 | 1.37462687 |
| 25 | NUAK1 | 1.34553515 |
| 26 | LRRK2 | 1.33672918 |
| 27 | MYLK | 1.32942804 |
| 28 | BUB1 | 1.32090614 |
| 29 | FLT3 | 1.31228603 |
| 30 | WEE1 | 1.29523470 |
| 31 | FES | 1.26323880 |
| 32 | PKN2 | 1.24895383 |
| 33 | SYK | 1.19355321 |
| 34 | MAP3K12 | 1.19246852 |
| 35 | STK16 | 1.13427171 |
| 36 | CLK1 | 1.12277489 |
| 37 | ITK | 1.11438649 |
| 38 | INSRR | 1.09963389 |
| 39 | VRK1 | 1.06860053 |
| 40 | CDK8 | 1.05989269 |
| 41 | GRK1 | 1.05828655 |
| 42 | CSF1R | 1.03167169 |
| 43 | GRK5 | 1.02962004 |
| 44 | RIPK1 | 1.01525891 |
| 45 | MAP3K14 | 1.01137267 |
| 46 | ACVR1B | 1.00068087 |
| 47 | NLK | 0.99846160 |
| 48 | GRK6 | 0.96661585 |
| 49 | TAOK3 | 0.95308641 |
| 50 | LCK | 0.94950600 |
| 51 | PAK4 | 0.93265867 |
| 52 | CSK | 0.93065945 |
| 53 | FER | 0.92895040 |
| 54 | BRSK2 | 0.90606183 |
| 55 | EIF2AK3 | 0.89694459 |
| 56 | PRKCQ | 0.88815711 |
| 57 | RPS6KA4 | 0.88337373 |
| 58 | EEF2K | 0.86536169 |
| 59 | MAP3K11 | 0.86064763 |
| 60 | PIM1 | 0.85020919 |
| 61 | LYN | 0.84869717 |
| 62 | MAP3K13 | 0.84609490 |
| 63 | MATK | 0.82225787 |
| 64 | HCK | 0.77198369 |
| 65 | TLK1 | 0.76790573 |
| 66 | NEK2 | 0.76775847 |
| 67 | CDC7 | 0.75364996 |
| 68 | FGR | 0.75301099 |
| 69 | PIK3CG | 0.73081630 |
| 70 | RPS6KB2 | 0.72624758 |
| 71 | BMPR2 | 0.71176090 |
| 72 | IKBKB | 0.70841671 |
| 73 | PRKG2 | 0.70356913 |
| 74 | MAP4K2 | 0.67604046 |
| 75 | TNIK | 0.66457926 |
| 76 | CDK7 | 0.66174297 |
| 77 | ADRBK2 | 0.65286959 |
| 78 | BMX | 0.65194060 |
| 79 | SIK3 | 0.62849782 |
| 80 | MAP3K1 | 0.61988018 |
| 81 | TSSK6 | 0.61674687 |
| 82 | RPS6KA6 | 0.58776848 |
| 83 | BMPR1B | 0.58769412 |
| 84 | ILK | 0.58652155 |
| 85 | DYRK3 | 0.58257834 |
| 86 | MAPK4 | 0.57750581 |
| 87 | CDK4 | 0.57554481 |
| 88 | CAMKK2 | 0.56905861 |
| 89 | STK4 | 0.56154885 |
| 90 | FGFR4 | 0.55026098 |
| 91 | MAPK12 | 0.54959619 |
| 92 | CCNB1 | 0.54362590 |
| 93 | JAK1 | 0.54134853 |
| 94 | MAP3K10 | 0.53406610 |
| 95 | EIF2AK1 | 0.52959689 |
| 96 | EPHA3 | 0.52927245 |
| 97 | SCYL2 | 0.51204941 |
| 98 | DAPK1 | 0.50953815 |
| 99 | PTK6 | 0.50560722 |
| 100 | IRAK1 | 0.49146502 |
| 101 | TESK2 | 0.49109256 |
| 102 | RPS6KL1 | 0.47085493 |
| 103 | RPS6KC1 | 0.47085493 |
| 104 | MST4 | 0.46839970 |
| 105 | EPHB1 | 0.45790991 |
| 106 | SRPK1 | 0.44288326 |
| 107 | MAPKAPK3 | 0.43092125 |
| 108 | MAP2K2 | 0.43065767 |
| 109 | TRPM7 | 0.41798587 |
| 110 | EIF2AK2 | 0.40498150 |
| 111 | PDK1 | 0.40276321 |
| 112 | ADRBK1 | 0.39804000 |
| 113 | ATR | 0.38780802 |
| 114 | PASK | 0.38122985 |
| 115 | CAMK1 | 0.37991925 |
| 116 | TESK1 | 0.37517662 |
| 117 | FYN | 0.37460882 |
| 118 | MARK3 | 0.37135279 |
| 119 | MAP3K3 | 0.37131617 |
| 120 | MKNK1 | 0.36038370 |
| 121 | PTK2B | 0.35715512 |
| 122 | BCKDK | 0.35549392 |
| 123 | ZAK | 0.35466245 |
| 124 | MAP3K6 | 0.34576426 |
| 125 | JAK2 | 0.34547405 |
| 126 | MAP2K6 | 0.34246237 |
| 127 | MAP3K7 | 0.34103991 |
| 128 | MAPK11 | 0.33837228 |
| 129 | MAPK7 | 0.32661879 |
| 130 | PRKCD | 0.32543268 |
| 131 | MAP3K8 | 0.32332482 |
| 132 | HIPK2 | 0.31176020 |
| 133 | IGF1R | 0.30541081 |
| 134 | AURKB | 0.30126865 |
| 135 | DAPK2 | 0.29521982 |
| 136 | FRK | 0.29150642 |
| 137 | DAPK3 | 0.29000516 |
| 138 | PRKD1 | 0.28254935 |
| 139 | GRK7 | 0.27392945 |
| 140 | INSR | 0.25946344 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 3.86122695 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 3.59720590 |
| 3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.42189703 |
| 4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.30911156 |
| 5 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.67619354 |
| 6 | Mismatch repair_Homo sapiens_hsa03430 | 2.57840582 |
| 7 | Base excision repair_Homo sapiens_hsa03410 | 2.50870547 |
| 8 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.24871922 |
| 9 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.07819982 |
| 10 | Leishmaniasis_Homo sapiens_hsa05140 | 2.03432723 |
| 11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.92255874 |
| 12 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.82291899 |
| 13 | Measles_Homo sapiens_hsa05162 | 1.81037339 |
| 14 | Homologous recombination_Homo sapiens_hsa03440 | 1.80912178 |
| 15 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.72410583 |
| 16 | Other glycan degradation_Homo sapiens_hsa00511 | 1.70148955 |
| 17 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.69992343 |
| 18 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.65926492 |
| 19 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.64707861 |
| 20 | Spliceosome_Homo sapiens_hsa03040 | 1.64463455 |
| 21 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.59890363 |
| 22 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.57058073 |
| 23 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.56696582 |
| 24 | Proteasome_Homo sapiens_hsa03050 | 1.50818823 |
| 25 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.50419559 |
| 26 | * Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.48119417 |
| 27 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.47266886 |
| 28 | Platelet activation_Homo sapiens_hsa04611 | 1.47051029 |
| 29 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.44062909 |
| 30 | Malaria_Homo sapiens_hsa05144 | 1.43313115 |
| 31 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.43050911 |
| 32 | Pertussis_Homo sapiens_hsa05133 | 1.41681908 |
| 33 | Viral myocarditis_Homo sapiens_hsa05416 | 1.32677799 |
| 34 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.30835587 |
| 35 | RNA polymerase_Homo sapiens_hsa03020 | 1.26991332 |
| 36 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.25246922 |
| 37 | Shigellosis_Homo sapiens_hsa05131 | 1.24690173 |
| 38 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.24177214 |
| 39 | Legionellosis_Homo sapiens_hsa05134 | 1.23724099 |
| 40 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.14153402 |
| 41 | Cell cycle_Homo sapiens_hsa04110 | 1.11523904 |
| 42 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.08806566 |
| 43 | Protein export_Homo sapiens_hsa03060 | 1.08294521 |
| 44 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.08180875 |
| 45 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.05743790 |
| 46 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.02798121 |
| 47 | RNA degradation_Homo sapiens_hsa03018 | 1.01059896 |
| 48 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.00202308 |
| 49 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.99888148 |
| 50 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.95749905 |
| 51 | Influenza A_Homo sapiens_hsa05164 | 0.95000676 |
| 52 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.94555073 |
| 53 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.94497179 |
| 54 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.94012768 |
| 55 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.93652989 |
| 56 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.93323532 |
| 57 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.89696550 |
| 58 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.88704241 |
| 59 | Purine metabolism_Homo sapiens_hsa00230 | 0.88690699 |
| 60 | Hepatitis B_Homo sapiens_hsa05161 | 0.87589103 |
| 61 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.87148077 |
| 62 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.87037390 |
| 63 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.86519540 |
| 64 | Apoptosis_Homo sapiens_hsa04210 | 0.85015548 |
| 65 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.83853057 |
| 66 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.83513247 |
| 67 | HTLV-I infection_Homo sapiens_hsa05166 | 0.82994713 |
| 68 | Sulfur relay system_Homo sapiens_hsa04122 | 0.82144469 |
| 69 | Allograft rejection_Homo sapiens_hsa05330 | 0.82029535 |
| 70 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.81876690 |
| 71 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.81438260 |
| 72 | Salmonella infection_Homo sapiens_hsa05132 | 0.81190206 |
| 73 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.79587813 |
| 74 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.79274827 |
| 75 | Phagosome_Homo sapiens_hsa04145 | 0.79181375 |
| 76 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.77300891 |
| 77 | Thyroid cancer_Homo sapiens_hsa05216 | 0.76726221 |
| 78 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.75570382 |
| 79 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.74547480 |
| 80 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.73432631 |
| 81 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.72102699 |
| 82 | RNA transport_Homo sapiens_hsa03013 | 0.71902825 |
| 83 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.67141789 |
| 84 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.66683277 |
| 85 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.66635400 |
| 86 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.66106744 |
| 87 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.61549429 |
| 88 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.61447947 |
| 89 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.61410851 |
| 90 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.56734998 |
| 91 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.56670914 |
| 92 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.56191474 |
| 93 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.55097201 |
| 94 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.53233870 |
| 95 | Endocytosis_Homo sapiens_hsa04144 | 0.53000563 |
| 96 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.52570718 |
| 97 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.51639224 |
| 98 | Tuberculosis_Homo sapiens_hsa05152 | 0.51019865 |
| 99 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.50616820 |
| 100 | Focal adhesion_Homo sapiens_hsa04510 | 0.50418051 |
| 101 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.48917101 |
| 102 | Hepatitis C_Homo sapiens_hsa05160 | 0.48173688 |
| 103 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.45753887 |
| 104 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.45579773 |
| 105 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.45059150 |
| 106 | Asthma_Homo sapiens_hsa05310 | 0.44548009 |
| 107 | Galactose metabolism_Homo sapiens_hsa00052 | 0.44400153 |
| 108 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.43546739 |
| 109 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.43093268 |
| 110 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.42459575 |
| 111 | * Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.41181552 |
| 112 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.41140013 |
| 113 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.39816618 |
| 114 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.39225017 |
| 115 | Phototransduction_Homo sapiens_hsa04744 | 0.38342137 |
| 116 | Parkinsons disease_Homo sapiens_hsa05012 | 0.36789704 |
| 117 | Pathways in cancer_Homo sapiens_hsa05200 | 0.36304112 |
| 118 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.34369988 |
| 119 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.33876750 |
| 120 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.33386620 |
| 121 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.33173382 |
| 122 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.33043474 |
| 123 | Olfactory transduction_Homo sapiens_hsa04740 | 0.30232474 |
| 124 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.28294489 |
| 125 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.28251795 |
| 126 | Lysosome_Homo sapiens_hsa04142 | 0.28001111 |
| 127 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.25006152 |
| 128 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.23210596 |
| 129 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.23089273 |
| 130 | Peroxisome_Homo sapiens_hsa04146 | 0.22547511 |
| 131 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.22241240 |
| 132 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.22031414 |
| 133 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.20133823 |

